Minerva Surgical Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $36.84 million
- Book Value:
- Revenue TTM:
- $52.32 million
- Operating Margin TTM:
- Gross Profit TTM:
- $27.24 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Minerva Surgical Inc had its IPO on 2021-10-22 under the ticker symbol UTRS.
The company operates in the Healthcare sector and Medical Devices industry. Minerva Surgical Inc has a staff strength of 174 employees.
Shares of Minerva Surgical Inc opened at $0.2 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.2 - $0.21, and closed at $0.21.
This is a -0.96% slip from the previous day's closing price.
A total volume of 29,752 shares were traded at the close of the day’s session.
In the last one week, shares of Minerva Surgical Inc have slipped by -0.96%.
Minerva Surgical Inc's Key Ratios
Minerva Surgical Inc has a market cap of $36.84 million, indicating a price to book ratio of 0.2791 and a price to sales ratio of 0.1163.
In the last 12-months Minerva Surgical Inc’s revenue was $52.32 million with a gross profit of $27.24 million and an EBITDA of $-28726000. The EBITDA ratio measures Minerva Surgical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Minerva Surgical Inc’s operating margin was -73.91% while its return on assets stood at -27.9% with a return of equity of -130.92%.
In Q2, Minerva Surgical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 3.3%.
Minerva Surgical Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-0.74 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Minerva Surgical Inc’s profitability.
Minerva Surgical Inc stock is trading at a EV to sales ratio of 0.613 and a EV to EBITDA ratio of -10.031. Its price to sales ratio in the trailing 12-months stood at 0.1163.
Minerva Surgical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $79.30 million
- Total Liabilities
- $18.08 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Minerva Surgical Inc ended 2023 with $79.30 million in total assets and $0 in total liabilities. Its intangible assets were valued at $79.30 million while shareholder equity stood at $26.59 million.
Minerva Surgical Inc ended 2023 with $0 in deferred long-term liabilities, $18.08 million in other current liabilities, 177000.00 in common stock, $-303537000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $15.71 million and cash and short-term investments were $15.71 million. The company’s total short-term debt was $8,987,000 while long-term debt stood at $31.08 million.
Minerva Surgical Inc’s total current assets stands at $46.08 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.95 million compared to accounts payable of $3.82 million and inventory worth $17.88 million.
In 2023, Minerva Surgical Inc's operating cash flow was $-13000.00 while its capital expenditure stood at $13000.
Comparatively, Minerva Surgical Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Minerva Surgical Inc stock is currently trading at $0.21 per share. It touched a 52-week high of $1.42 and a 52-week low of $1.42. Analysts tracking the stock have a 12-month average target price of $1.
Its 50-day moving average was $0.24 and 200-day moving average was $0.25 The short ratio stood at 0.6 indicating a short percent outstanding of 0%.
Around 42.7% of the company’s stock are held by insiders while 9357.2% are held by institutions.
Frequently Asked Questions About Minerva Surgical Inc
Similar Industry Stocks (Medical Devices)
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.